BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16616188)

  • 1. Identification of the key LMO2-binding determinants on Ldb1.
    Ryan DP; Sunde M; Kwan AH; Marianayagam NJ; Nancarrow AL; Vanden Hoven RN; Thompson LS; Baca M; Mackay JP; Visvader JE; Matthews JM
    J Mol Biol; 2006 May; 359(1):66-75. PubMed ID: 16616188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia.
    Grutz G; Forster A; Rabbitts TH
    Oncogene; 1998 Nov; 17(21):2799-803. PubMed ID: 9840944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the recognition of ldb1 by the N-terminal LIM domains of LMO2 and LMO4.
    Deane JE; Mackay JP; Kwan AH; Sum EY; Visvader JE; Matthews JM
    EMBO J; 2003 May; 22(9):2224-33. PubMed ID: 12727888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
    Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
    Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, production and characterization of FLIN2 and FLIN4: the engineering of intramolecular ldb1:LMO complexes.
    Deane JE; Sum E; Mackay JP; Lindeman GJ; Visvader JE; Matthews JM
    Protein Eng; 2001 Jul; 14(7):493-9. PubMed ID: 11522923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tandem LIM domains provide synergistic binding in the LMO4:Ldb1 complex.
    Deane JE; Ryan DP; Sunde M; Maher MJ; Guss JM; Visvader JE; Matthews JM
    EMBO J; 2004 Sep; 23(18):3589-98. PubMed ID: 15343268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional control of fetal liver hematopoiesis: dominant negative effect of the overexpression of the LIM domain mutants of LMO2.
    Terano T; Zhong Y; Toyokuni S; Hiai H; Yamada Y
    Exp Hematol; 2005 Jun; 33(6):641-51. PubMed ID: 15911088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Identification of interaction partners and function analysis of new splicing product of human LMO2 gene].
    Yuan W; Yang S; Sun W; Du J; Zhai CL; Wang ZQ; Zhu TH
    Zhonghua Xue Ye Xue Za Zhi; 2008 May; 29(5):325-8. PubMed ID: 18844071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins.
    Wadman IA; Osada H; Grütz GG; Agulnick AD; Westphal H; Forster A; Rabbitts TH
    EMBO J; 1997 Jun; 16(11):3145-57. PubMed ID: 9214632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
    El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
    Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of the LIM-domain-binding factor Ldb1 with LIM homeodomain proteins.
    Agulnick AD; Taira M; Breen JJ; Tanaka T; Dawid IB; Westphal H
    Nature; 1996 Nov; 384(6606):270-2. PubMed ID: 8918878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competition between LIM-binding domains.
    Matthews JM; Bhati M; Craig VJ; Deane JE; Jeffries C; Lee C; Nancarrow AL; Ryan DP; Sunde M
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1393-7. PubMed ID: 19021562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LIM domain binding proteins 1 and 2 have different oligomeric states.
    Cross AJ; Jeffries CM; Trewhella J; Matthews JM
    J Mol Biol; 2010 May; 399(1):133-44. PubMed ID: 20382157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The LMO1 and LDB1 proteins interact in human T cell acute leukaemia with the chromosomal translocation t(11;14)(p15;q11).
    Valge-Archer V; Forster A; Rabbitts TH
    Oncogene; 1998 Dec; 17(24):3199-202. PubMed ID: 9872335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lim-only protein LMO2 acts as a positive regulator of erythroid differentiation.
    Hansson A; Zetterblad J; van Duren C; Axelson H; Jönsson JI
    Biochem Biophys Res Commun; 2007 Dec; 364(3):675-81. PubMed ID: 17964543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells.
    Grütz GG; Bucher K; Lavenir I; Larson T; Larson R; Rabbitts TH
    EMBO J; 1998 Aug; 17(16):4594-605. PubMed ID: 9707419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation.
    Visvader JE; Mao X; Fujiwara Y; Hahm K; Orkin SH
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13707-12. PubMed ID: 9391090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.
    Layer JH; Alford CE; McDonald WH; Davé UP
    Mol Cell Biol; 2016 Feb; 36(3):488-506. PubMed ID: 26598604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of chromosomal translocations in acute leukemias: the LMO2 paradigm in transcription and development.
    Rabbitts TH; Bucher K; Chung G; Grutz G; Warren A; Yamada Y
    Cancer Res; 1999 Apr; 59(7 Suppl):1794s-1798s. PubMed ID: 10197599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of a tethered Lmo2(LIM2) /Ldb1(LID) complex.
    Dastmalchi S; Wilkinson-White L; Kwan AH; Gamsjaeger R; Mackay JP; Matthews JM
    Protein Sci; 2012 Nov; 21(11):1768-74. PubMed ID: 22936624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.